IL17A and colorectal carcinoma: Considerable evidence suggests that increased expression profiles of the TH17 cytokine product, IL-17A, are associated with the production of the proangiogenic factor vascular endothelial growth factor (VEGF) and poor prognosis in patients with CRC (93).